Therapeutic options for regionally advanced non-small cell lung cancer

Lung Cancer

Volumn 14, Issue 2-3, 1996, Pages 281-300

  Buccheri, Gianfranco ^a,b,c   Ferrigno, Domenico ^a  

^a 'A Carle' Hosp of Chest Diseases   (Italy)

^b Ospedale A Carle ^*  (Italy)

^c S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Chemotherapy; Locally advanced disease; Non small cell lung cancer; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; MITOMYCIN; VINBLASTINE; VINCA ALKALOID;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; HUMAN; LUNG NON SMALL CELL CANCER; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0029896516     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(96)00554-5     Document Type: Article

References (85)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer Statistics, 1994. CA Cancer J Clin 1994; 44: 7-26.
2. Wilde J, Haenselt V, Luft D. The impact of histological type and tumour localisation on the prognosis in 1000 resected lung cancer patients with special view to adenocarcinoma. Pneumologie 1990; 44: 1287-1293.
3. Rossing TH, Rossing RG. Survival in lung cancer. An analysis of the effects of age, sex, resectability, and histopathologic type. Am Rev Respir Dis 1982; 126: 771-777.
4. Minna JD, Higgins GA, Glatstein EJ. Cancer of the lung. In: De Vita VT, Jr, Hellman S, Rosenberg SA, editors. Cancer. Principles and practice of oncology. Philadelphia, PA : J.B. Lippincott Co., 1985; 507-597.
5. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89 (Suppl): 225S-233S.
6. UICC. TNM Classification of malignant tumours. Berlin: Springer, 1987; 69-73.
7. World Health Organization. International histological classification of tumours. Berlin: Springer, 1991.
8. American Joint Committee on Cancer. Purposes and principles of staging. In: Beahrs OH, Earl Henson D, Hutter RVP, Myers MH, editors. Manual for staging of cancer. Philadelphia, PA: Lippincott, 1988; 3-10.
9. Lederle FA, Niewochner DE. Lung cancer surgery: a critical review of the evidence. Arch Intern Med 1994; 154: 2397-2400.
10. Kayser K, Bulzebruck H, Probst G, Vogt-Moykopf I. Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients. Cancer 1987; 59: 355-361.
11. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995; 109: 120-129.
12. Haskell CM. Chemotherapy and survival of patients with non-small cell lung cancer: a contrary view. Chest 1991; 99: 1325-1326.
13. Vokes EE, Bitran JD, Vogelzang NJ. Chemotherapy for non-small cell lung cancer: a continuing challenge. Chest 1991; 99: 1326-1328.
14. Buccheri GF. Chemotherapy and survival in non-small cell lung cancer. The old 'vexata questio'. Chest 1991; 99: 1328-1329.
15. Masters GA, Vokes EE. Should non-small cell carcinoma of the lung be treated with chemotherapy? Pro: Chemotherapy is for non-small cell lung cancer. Am J Respir Crit Care Med 1995; 151: 1285-1287.
16. Douglas IS, White SR. Should non-small cell carcinoma of the lung be treated with chemotherapy? Con: Therapeutic empiricism - The case against chemotherapy in non-small cell lung cancer. Am J Respir Crit Care Med 1995; 151: 1288-1291.
17. Johnson DH. Chemotherapy for metastatic non-small-cell lung cancer - Can that dog hunt. J Natl Cancer Inst 1993; 85: 766-767.
18. Coates A, Forbes J. Is chemotherapy for non-small cell lung cancer worthwhile. Lancet 1993; 342: 4.
19. Smith IE. Palliative chemotherapy for advanced non-small cell lung cancer. Br Med J 1994; 308: 429-430.
20. Buccheri G. Chemotherapy and survival in non-small cell lung cancer: Three years later. Chest 1994; 106: 990-992.
21. Belani CP. Multimodality management of regionally advanced non-small-cell lung cancer. Semin Oncol 1993; 20: 302-314.
22. Wolf J, Spear P, Yesner R, Patno ME. Nitrogen mustard in the palliative treatment of inoperable bronchogenic carcinoma. Am J Med 1960; 29: 1008-1022.
23. Green RA, Humphrey E, Close H, Patno ME. Alkylating agents in bronchogenic carcinoma. Am J Med 1969; 46: 516-525.
24. Selawry O, Krant M, Scotto J. Methotrexate compared with placebo in lung cancer. Cancer 1977; 40: 4-8.
25. Cormier Y, Bergeron D, La Forge J, Lavandier M, Fournier M, Chenard J et al. Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma. Cancer 1982; 50: 845-849.
26. Rapp E, Pater JL, Willan A, Cormier Y, Murray N, Evans WK et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer - Report of a Canadian multicenter randomized trial. J Clin Oncol 1988; 6: 633-641.
27. Woods RL, Williams CJ, Levi J, Page J, Bell D, Byrne M et al. A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 1990; 61: 608-611.
28. Buccheri GF, Ferrigno D, Rosso A, Vola F. Further evidence in favour of chemotherapy for inoperable non-small cell lung cancer. Lung Cancer 1990; 6: 87-98.
29. Cellerino R, Tummarello D, Guidi F, Isidori P, Raspugli M, Biscottini B et al. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer. J Clin Oncol 1991; 9: 1453-1461.
30. Thongprasert S, Sanguanmitra P, Umsawasdi T. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy. Proc Am Soc Clin Oncol (Abstr) 1995; 14: 358.
31. Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J, for the UCLA Solid Tumor Study Group. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference? Cancer 1989; 63: 1271-1278.
32. Quoix E, Dietemann A, Charbonneau J, Boutin C, Maurice JC, Pauli G et al. Disseminated non-small cell lung cancer (NSCLC): a randomized trial of chemotherapy (CT) versus palliative care (PC). Lung Cancer 1988; 4 Suppl 1: 127a (Abstr).
33. Kaasa S, Lund E, Thorud E, Hatlevoll R, Host H. Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer. Cancer 1991; 67: 2443-2447.
34. Cartei G, Cartei F, Cantone A, Causarano D, Genco G, Tobaldin A et al. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer. J Natl Cancer Inst 1993; 85: 794-800.
35. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA et al. Polychemotherapy in advanced non small cell lung cancer: A meta-analysis. Lancet 1993; 342: 19-21.
36. Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough. J Clin Oncol 1993; 11: 1866-1872.
37. Marino P, Pampallona S, Preatoni A, Cantoni A, Invernizzi F. Chemotherapy vs. supportive care in advanced non-small-cell lung cancer: Results of a meta-analysis of the literature. Chest 1994; 106: 861-865.
38. Pignon J-P, Stewart LA, Souhami RL, Arriagada R, NSCLC Collaborators Group. A meta-analysis using individual patient data from randomised clinical trials (RCTS) of chemotherapy (CT) in non-small cell lung cancer (NSCLC): (2) survival in the locally advanced (LA) setting. Proc Am Soc Clin Oncol 1994; 13: 334 (Abstr 1109).
39. Johnson BE. Biologic and molecular prognostic factors - Impact on treatment of patients with non-small cell lung cancer. Chest 1995; 107 Suppl: 287S-290S.
40. Roswit B, Patno ME, Rapp R, Veinbergs A, Feder B, Stuhlbarg J et al. The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology 1968; 90: 688-697.
41. Gregor A, Macbeth FR, Paul J, Cram L, Hansen HH. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: A randomized trial. J Natl Cancer Inst 1993; 85: 997-999.
42. Kjaer M. Radiotherapy of squamous, adeno- and large cell carcinoma of the lung. Cancer Treat Rev 1982; 9: 1-20.
43. Cox JD, Byhardt RW, Komaki R. The role of radiotherapy in squamous, large cell, and adenocarcinoma of the lung. Semin Oncol 1983; 10: 81-94.
44. Berry RJ, Laing AH, Newman CR, Peto J. The role of radiotherapy in treatment of inoperable lung cancer. Int J Radiat Oncol Biol Phys 1977; 2: 433-439.
45. Caldwell WL, Bagshaw MA. Indications for and results of irradiation of carcinoma of the lung. Cancer 1968; 22: 999-1004.
46. Deeley TJ, Singh SP. Treatment of inoperable carcinoma of the bronchus by megavoltage X-rays. Thorax 1967; 22: 562-566.
47. Abe S, Makimura S, Itabashi K, Nagai T, Tsuneta Y, Kawakami Y. Prognostic significance of nuclear DNA content in small cell carcinoma of the lung. Cancer 1985; 56: 2025-2030.
48. Roswit B. Radiation therapy and radioisotopes. In: Spain DM, editor. Diagnosis and treatment of tumors of the chest. New York: Grune and Stratton, 1990; 299-334.
49. Perez CA, Stanley K, Grundy G, Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell bronchogenic carcinoma of the lung. Cancer 1982; 50: 1091-1099.
50. Hillers TK, Sauve MD, Guyatt GH, Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax 1994; 49: 14-19.
51. Bunn PA, Jr, Kelly K. The role of routine chest radiotherapy in small-cell lung cancer: An issue of timing and stage. Chest 1993; 104: 661-662.
52. Bleehen NM, Ball D, Belani CP, Bishop J, Douillard J-Y, Cox JD et al. Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma. Lung Cancer 1994; 10 Suppl 1: S19-S23.
53. Kaasa S, Thorud E, Host H, Lien HH, Lund E, Sjolie I. A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small cell lung cancer. Radiother Oncol 1988; 11: 7-13.
54. Johnson DH, Einhorn LH, Bartolucci A, Birch R, Omura G, Perez CA et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 1990; 113: 33-38.
55. Durrant KR, Berry RJ, Ellis F. Comparison of treatment policies in inoperable bronchial carcinoma. Lancet 1971; 10: 715-719.
56. Laing AH, Berry RJ, Newman CR, Peto J. Treatment of inoperable carcinoma of the bronchus. Lancet 1975; ii: 1161-1164.
57. Leung WT, Shiu WCT, Pang JCK, Lau J, Tao M, Leung SF et al. Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small-cell lung cancer. Oncology 1992; 49: 321-326.
58. Blumenreich MS, Woodcock TM, Gentile PS, Barnes GR, Jose B, Sherrill EJ et al. High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer. J Clin Oncol 1987; 5: 1725-1730.
59. Kubota K, Furuse K, Kawahara M, Kodama N, Yamamoto M, Ogawara M et al. Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer. J Clin Oncol 1994; 12: 1547-1552.
60. Landgren RC, Hussey DH, Barkley HT, Samuels ML. Split-course irradiation compared to split-course irradiation plus hydroxyurea in inoperable bronchogenic carcinoma. A randomized study of 53 patients. Cancer 1974; 34: 1598-1601.
61. Chan PYM, Byfield JE, Kagan AR, Aronstam EM. Unresectable squamous cell carcinoma of the lung and its management by combined bleomycin and radiotherapy. Cancer 1976; 37: 2671-2676.
62. White JE, Chen T, Reed R, Mira J, Stuckey WJ, Weatherall T et al. Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy. Cancer Treat Rep 1982; 66: 1113-1120.
63. Privitera G, Ciottoli GB, Patane C, Palmucci T, Tafuri G, Marietta F et al. Phase III double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung. Radiat Oncol 1987; 10: 285-290.
64. Soresi E, Clerici M, Grilli R, Zucali R, Leoni M, Botturi M et al. A randomized clinical trial comparing radiation therapy versus radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Semin Oncol 1988; 15: 20-25.
65. Mattson K, Holsti LR, Jakobsson M, Kajanti M, Liippo K, Mantyla M et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988; 24: 477-482.
66. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. New Engl J Med 1990; 323: 940-945.
67. Trovò MG, Minatel E, Veronesi A, Roncadin M, De Paoli A, Franchin G et al. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. Cancer 1990; 65: 400-404.
68. Le Chevalier T, Arriagada R, Quoix E, Ruffle P, Martin M, Lacombe-Terrier M-J et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417-423.
69. Le Chevalier T, Arriagada R, Tarayre M, Lacombe-Terrier M-J, Laplanche A, Quoix E et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. J Natl Cancer Inst 1992; 84: 58.
70. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 1991; 115: 681-686.
71. Trovò MG, Minatel E, Franchin G, Boccieri MG, Nascinben O, Bolzicco G et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992; 24: 11-15.
72. Schaake-Koning C, Van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, Van Houtte P et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. New Engl J Med 1992; 326: 524-530.
73. Wolf M, Hans K, Becker H, Hassler R, Von Bultzingslowen F, Goerg R et al. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. Semin Oncol 1994; 21 Suppl. 4: 42-47.
74. Jeremic B, Shibamoto Y, Acimovic L, Djuric L. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol 1995; 13: 452-458.
75. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588. Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87: 198-205.
76. Blanke C, Ansari R, Mantravadi R, Gonin R, Tokars R, Fisher W et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: A Hoosier Oncology Group protocol. J Clin Oncol 1995; 13: 1425-1429.
77. Cullen MH. Trials of radical radiotherapy versus chemotherapy plus radical radiotherapy in non-small cell lung cancer. Semin Oncol 1994; 21 Suppl 4: 34-41.
78. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987; 67: 1037-1049.
79. Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, Cantó A et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. New Engl J Med 1994; 330: 153-158.
80. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Jr, Lee JS et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994; 86: 673-680.
81. Pisters KMW, Kris MG, Gralla RJ, Zaman MB, Heelan RT, Martini N. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: Implications for the design of future non-small-cell lung cancer combined modality trials. J Clin Oncol 1993; 11: 1757-1762.
82. Albain KS. Induction therapy followed by definitive local control for stage III non-small cell lung cancer: a review with a focus on recent tri-modality trials. Chest 1993; 103: 43s-50s.
83. Shepherd FA. Current review: induction chemotherapy for locally advanced non-small cell lung cancer. Ann Thorac Surg 1993; 55: 1585-1592.
84. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1982; 1: 121-129.
85. Slevin ML, Stubbs L, Plant HJ. Attitudes to chemotherapy: comparing views of patients with cancer and those of doctors, nurses, and general public. Br Med J 1990; 300: 1458-1460.